blindness from glp-1 Ozempic Blindness: Should You Worry? GLP-1 NAION Vision Loss Lawsuit

( Table 7 )

The analogue, liraglutide, was effective in clinical studies (the LEAD trials [16]) and was subsequently tested in a cardiovascular outcome trial, the LEADER trial [17], as demanded by the FDA for new antidiabetic agents

10.1016/j.numecd.2016.01.011 32

Additionally, the exploration of additional indications beyond diabetes, such as obesity and non-alcoholic fatty liver disease, represents a significant market expansion possibility

At the same time, obesity and type 2 diabetes continue to affect millions of women who may become pregnant unexpectedly

Given semaglutides structural similarity to GLP-1, the presence of GLP-1 analogs in milk via active transport is a possible infant health concern